MBNL1 and myotonic dystrophy type 1: Furthermore, we identified pharmacological compounds reducing MBNL1 sequestration by expanded CUG repeats and found that one of these drugs, daunorubicin hydrochloride, achieved a complete rescue of cardiac parameters, including survival, arrhythmia, %FS and HP, with an increase of both DI and SI in DM1 flies.